Biotech funding plummets as Trump insurance policies unnerve buyers: Jefferies

The funding financial institution says funding was down 57% final month, to $2.7 billion, and argues the brand new administration’s FDA restructuring, NIH cuts and drug pricing guidelines are “exacerbating” the decline.